Home > News > Nanotech Puts Cancer In The Cross Hairs
February 22nd, 2008
Nanotech Puts Cancer In The Cross Hairs
Abstract:
Unfortunately, when it comes to treating cancer, modern medicine is still in its infancy. By and large, we still rely on debilitating chemotherapy regimens which take a shotgun approach to curing cancer by essentially poisoning patients in an effort to eradicate tumors.
But nanotech represents a bright spot in the fight against cancer. Researchers are increasingly turning to new, innovative therapies, based on particles measuring less than 200 nanometers. At that scale, particles passively target weaker-walled cancer cells and help localize treatment, increasing its effectiveness while minimizing damage to healthy tissue.
The medication Doxil, produced by Ortho Biotech Products LP--a unit of Johnson & Johnson (nyse: JNJ - news - people )--uses this approach to treat certain myeloma and ovarian cancers. It incorporates chemotherapy into 100-nm liposome particles that circulate through the blood over long periods and slip into the pores of tumor blood vessels, helping to concentrate treatment at the disease site.
Source:
forbes.com
Bookmark:
| Related News Press |
News and information
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025
First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025
Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||